ArticleAnnals of gastroenterological surgery2026
Prediction of Long-Term Prognosis in Patients With Hepatocellular Carcinoma Using the National Clinical Database Risk Calculator.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To determine the value of the National Clinical Database (NCD) risk calculator for predicting surgical outcomes and long-term prognosis in patients undergoing resection for hepatocellular carcinoma (HCC). Methods: We retrospectively analyzed data from 210 patients with HCC who underwent initial hepatic resection between January 2016 and December 2022. We calculated predicted incidence of surgery-related mortality (predicted mortality rate) using the NCD risk calculator. We assessed the relationship between predicted mortality rate and clinicopathological factors, including their relationship with long-term prognosis. Results: A predicted mortality rate of ≥ 3% significantly correlated with worse recurrence-free survival and overall survival (OS), with a high-risk group showing increased blood loss, longer hospital stays, and higher severe complication rates. Multivariate analysis identified predicted mortality rate of ≥ 3% as an independent prognostic indicator for poor OS, alongside male sex and microvascular invasion. Conclusion: The NCD risk calculator showed potential to predict not only short-term outcomes but also long-term prognosis in patients with HCC undergoing resection. The NCD risk calculator may be a valuable complementary tool for decision-making about liver resection in patients with HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.